
‘Cover-ups' surrounding care of Nottingham attack killer, victim's mother claims
Valdo Calocane, who had been diagnosed with paranoid schizophrenia, killed three people – 19-year-old students Grace O'Malley-Kumar and Barnaby Webber and 65-year-old caretaker Ian Coates – and attempted to kill three more in Nottingham in June 2023.
A February report into the care received by Calocane detailed how he was not forced to have long-lasting antipsychotic medication because he did not like needles, and how other patients at Nottinghamshire Healthcare NHS Foundation Trust also went on to commit 'extremely serious' acts of violence.
Families of the victims met with Health Secretary Wes Streeting on Monday and said they told him they want the names of staff involved in treating Calocane to be made public.
Speaking on ITV's Good Morning Britain on the second anniversary of the attack, Barnaby Webber's mother Emma Webber said of Calocane's care: 'We quite often say, imagine anything that could go wrong, did go wrong and Wes Streeting actually, to quote him, he said 'sunlight is the best disinfectant'.
'That's appropriate but, actually, I would say it's simpler than that.
'I think truth is and once you've got the truth, then you've got somewhere to begin, and we're still getting cover-ups, we're still getting mistruths and we're still getting those push-aside emails 'well, the trust will deal with that, or the inquiry will deal with that'.
'But, no, we're not going to stop.
'I don't know when they'll learn that we will not stop until we get those answers.'
Ms Webber added that the families' calls for transparency were 'not a witch hunt'.
She said: 'I'm sure it can come across that we as families are just so vociferous in finding answers and trying to deal with our grief and our anger and rage at what happened.
'But it's much deeper than that, and it's greater than that, because there are individuals out there that they're posing a risk themselves, but they're posing a risk to the public, and we're not on a witch hunt in what we're doing.
'We do have the statutory inquiry coming up but that shouldn't stop individuals who, just as basic as failing to do their jobs properly, from being held to account, and that's through the professional means.
'I cannot understand how the NHS have not been able to confirm that anyone has had any disciplinary action against them for what they did or didn't do during his care.'
Grace O'Malley-Kumar's father, Dr Sanjoy Kumar, told the programme that the families do not have 'detailed answers' and called for 'full transparency' and 'true accountability'.
He said: 'At this juncture, I think it's turned into a national representation case for us, because I think what we've realised is that every family that goes through a horrific tragedy like us, they're not given answers, and they're given a lot of kerfuffle about what happened when, that's all very interesting, the timelines are interesting, but what we want is true accountability.
'Because when we have accountability, we can then have change and positive change for the country, and we've not had that, and that's been really, really frustrating.'
Calocane was sentenced to an indefinite hospital order in January 2024 after admitting manslaughter by diminished responsibility and attempted murder.
He was admitted to hospital and sectioned under the Mental Health Act four times between 2020 and 2022 because of his violent behaviour and refusal to take his medication, before NHS services lost track of him and discharged him in the months before the attacks.
Three reports, including one by the Care Quality Commission (CQC), described failings in his care but none included practitioners' names, Dr Kumar said after meeting Mr Streeting.
On Friday, the families of the victims will hold a memorial walk through Nottingham to remember their loved ones two years after their deaths.
They will meet at St Paul's Church in Lenton Road at 11.30am before walking to the two locations of the attacks.
During the interview with Good Morning Britain, Ms Webber said she had a 'visceral reaction' to returning to the city, adding that 'feels almost like it was yesterday' that the attack happened.
She added that the group wanted to 'walk in peace and love', and that anyone who wanted to join was 'very welcome'.
In a statement, Ifti Majid, chief executive of Nottinghamshire Healthcare NHS Foundation Trust, said: 'We are committed to giving our fullest co-operation and support to the Nottingham Inquiry which has already begun to request documentary evidence from ourselves and other organisations in relation to the devastating events of June 2023.
'It would be inappropriate to comment further at this stage.'
The Department of Health and Social Care has been contacted for comment.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mirror
an hour ago
- Daily Mirror
UKHSA issues urgent health warning after walking outdoors
People have been urged to look out for ticks, small creatures that can carry a number of infections. Brits have been issued an urgent warning to take care when walking outdoors this summer due to a serious risk to health. The UK Health Security Agency (UKHSA) has shared guidance on how to stay safe from ticks. Ticks are tiny, spider-like creatures that live in undergrowth and latch on to animals including humans when they walk through long grass. They are becoming more prevalent in parts of the UK, mainly due to increasing numbers of deer. While feeding, they can transmit viruses and infections that cause disease, with the most common being Lyme disease. In a post made to X, the UKHSA said: 'Summer's a great time to get outside, but ticks love the outdoors too. 'If you're walking through grassy or wooded areas, take a look at our guidance to help you stay safe and be tick aware.' In an infographic, it explained what to do if you find a tick on your body. What to do if you've been bitten by a tick 'Remove ticks as soon as you find them,' it said. 'If you have a tick removal device, follow its instructions or use a pair of fine-tipped tweezers.' Next you need to grasp the tick 'as close to the skin as you can'. The UKHSA explained: 'Pull upwards firmly, making sure all of the tick is removed.' You then need to clean the bite area with soap and water, and keep an eye on it for a few weeks in case of 'any changes' The health authority warned: 'Look out for a spreading bullseye rash, which is a common symptom of Lyme disease three to 30 days after being bitten. 'If you become unwell, for example with a spreading circular rash, flu-like symptoms, nerve pain or a droop on one or both sides of the face within a few weeks of a tick bite, call your GP practice or NHS 111.' Other potential symptoms of Lyme disease include: A high temperature, or feeling hot and shivery Headache Muscle and joint pain Tiredness and loss of energy The NHS warns that some people who are diagnosed and treated for Lyme disease continue to have symptoms, like tiredness, aches and loss of energy, that can last for years. 'These symptoms are often compared to fibromyalgia and chronic fatigue syndrome,' it says. 'It's not clear why this happens to some people and not others. This means there's also no agreed treatment.' You should speak to a doctor if your symptoms come back, or do not improve, after treatment with antibiotics. To reduce the risk of being bitten by a tick in the first place, the NHS recommends you:


The Independent
an hour ago
- The Independent
Thousands of NHS patients ‘to be denied breakthrough Alzheimer's drugs'
Breakthrough drugs that slow the progression of Alzheimer's disease will reportedly be refused for use on the NHS this week in a blow to thousands of patients. The two drugs, Lecanemab and donanemab, slow down the decline in Alzheimer's patients' ability to carry out daily activities. The drugs' success in halting the progression of Alzheimer's was heralded as a 'new era' by campaigners and researchers. However, the National Institute for Health and Care Excellence (Nice) is expected to refuse to recommend them on the NHS, according to The Sunday Times. The regulator has already issued two decisions, one in October last year and another in March, saying they would not recommend the drugs for use on the NHS. A final decision will be published on Thursday. Both drugs already have UK drug licences, making them available privately. It is estimated that around 70,000 adults in England would have been eligible for treatment if the drugs had been approved. The regulator will reportedly turn down both drugs on the grounds of cost-effectiveness, with one insider telling The Sunday Times: 'It is the end of the road for these drugs on the NHS'. Lecanemab removes build-ups of the protein beta-amyloid from the brain. Trials showed that lecanemab can slow the progression of Alzheimer's by 27 per cent over 18 months if given to someone early on in the course of their decline. Donanemab, marketed as Kisunla in the UK, teaches the body's immune cells to recognise and remove the amyloid protein, which builds up in the brains of people with Alzheimer's disease. The protein build-ups are thought to be toxic to brain cells, leading to the symptoms of Alzheimer's, the Alzheimer's society has said. Lecanemab can, however, cause swelling and bleeding in the brain. In trials for Donanemab, a third of recipients experienced abnormalities in their brain scans caused by brain swelling and bleeding, NICE said. The drugs reportedly cost around £20,000 to £25,000, with the NHS being offered a lower price. Privately, the treatment costs between £60,000-80,000 per year, according to Alzheimer's Research UK. In a previous review by NICE in October 2024, director of medicines evaluation Helen Knight said: 'Donanemab could slow down cognitive decline by 4-7 months, but this is just not enough benefit to justify the additional cost to the NHS. The cost-effectiveness estimate for donanemab is five to six times above what NICE normally considers an acceptable use of NHS resources'. While the regulator said the decision would be disappointing for some, 'there are other treatments being developed'. Hilary Evans-Newton, chief executive of Alzheimer's Research UK, said the decision to turn down the drugs would be 'deeply disappointing'. She added: 'These treatments are not perfect, and we recognise the challenges they pose around cost, delivery and safety. But scientific progress is incremental, and these drugs represent a vital foundation to build on.' The regulator NICE is due to publish the final draft guidance about the two drugs on Thursday. This leaves space for the decision to be challenged and sent to a review panel before the final guidance is published.


BBC News
2 hours ago
- BBC News
Herne Bay man has bladder tumours treated as NHS outpatient
A father-of-four has had bladder tumours removed as an outpatient at a Kent hospital through a pioneering new Payne, from Herne Bay, watched on-screen as surgeons removed a small tumour from his bladder via a procedure known as trans urethral laser 67-year-old, who underwent the procedure last week at Kent and Canterbury Hospital, says he was "absolutely blown over by the experience and the technology".Mr Payne had a previous tumour removed under general anaesthetic four years ago at an East Kent Hospitals University NHS Foundation Trust hospital. He said he was "a little bit nervous" before undergoing the new procedure, as he feared it might not be as effective."But it was exactly the same, just without the general anaesthetic," he said."I watched it on screen. I could see everything, and it was just like watching a documentary. I was even able to direct the consultant to where the tumour was." 'Major step forward' The procedure saw lead consultant for superficial bladder cancer, Georgios Papadopoulos, insert a thin flexible tube with a camera and light into Mr Payne's then took biopsies of the tumour before it was removed using a laser. Any remaining cancer cells were killed using chemotherapy. Mr Papadopoulos said: "This is a major step forward in how we treat patients with small tumours in their bladder."The Prostate Cancer Support Association Kent donated two laser machines, while the League of Friends of the Kent and Canterbury Hospital also helped provide funding.